Oramed Pharmaceuticals Inc. - Common Stock (NQ:ORMP)

4.445 -0.045 (-1.00%)

Delayed Quote Updated: 11:35 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Oramed Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 12, 2023

Via Benzinga

Wall Street Divided After Key Inflation Reading ↗

January 12, 2023

Stocks are a mixed bag midday, despite this morning's encouraging consumer price index (CPI).

Via Talk Markets

US Stocks Turn Higher; Dow Jumps 200 Points ↗

January 12, 2023

U.S. stocks turned higher midway through trading, following the release of inflation data.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 12, 2023

On Thursday, 13 stocks hit new 52-week lows.

Via Benzinga

Why Oramed Pharmaceuticals Stock Is Crashing Today ↗

January 12, 2023

The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.

Via The Motley Fool

Looking Into Oramed Pharmaceuticals's Return On Capital Employed ↗

December 22, 2022

Via Benzinga

Oramed Pharma Shares Fall After Additional Data From Oral Insulin Study ↗

November 17, 2022

Via Benzinga

Oramed Pharmaceuticals' Oral COVID-19 Vaccine Candidate Shows Safety, Immunogenicity In Early Study ↗

October 07, 2022

Via Benzinga

AVCT Stock Falls as American Virtual Cloud Technologies Files for Bankruptcy ↗

January 12, 2023

American Virtual Cloud Technologies (AVCT) stock is taking a beating on Thursday as the company, and two subsidiaries, file for bankruptcy.

Via InvestorPlace

Why Is Oramed (ORMP) Stock Down 75% Today? ↗

January 12, 2023

Oramed (ORMP) stock is falling hard Thursday after announcing a Phase 3 clinical trial of its diabetes treatment missed its primary endpoint.

Via InvestorPlace

Dow Drops 150 Points; US Inflation Rate Slows In December ↗

January 12, 2023

U.S. stocks traded lower this morning, following the release of inflation data.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 12, 2023

Via Benzinga

Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket ↗

January 12, 2023

Gainers Akerna Corp. (NASDAQ: KERN) rose 97.4% to $1.91 in pre-market trading after the company reported the sale of 365 Cannabis for $2.8 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 12, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

Oramed Pharma Shares Sink After Diabetes Candidate Fails In Phase 3 Study ↗

January 12, 2023

Oramed Pharmaceuticals Inc (NASDAQ: ORMP) announced top-line results from its Phase 3 trial (ORA-D-013-1) comparing the efficacy of ORMD-0801 to placebo in patients with Type 2 Diabetes (T2D) at 26...

Via Benzinga

Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

January 12, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Jim Cramer Says Avoid This Stock: 'Too Expensive' ↗

January 05, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Blackline, Inc. (NASDAQ: BL) was an enterprise software company that was losing money.

Via Benzinga

Li Auto, XPeng, Nio And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

January 03, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary ↗

September 13, 2022

Via Benzinga

Oramed Oral Insulin Shows Evidence For NASH Treatment ↗

September 13, 2022

Oramed Pharmaceuticals Inc (NASDAQ: ORMP) announced Phase 2 results from its trial of its oral insulin candidate (ORMD-0801) to reduce liver fat content in Type 2 Diabetes (T2D) patients with...

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary ↗

July 26, 2022

Via Benzinga

Oramed Accomplishes 50 Percent Enrolment In Late-Stage Oral Insulin Study ↗

July 26, 2022

Oramed Pharmaceuticals (NASDAQ: ORMP) has enrolled over 50 percent of the planned 450 patients for its international multicenter Phase 3 ORA-D-013-2 trial of oral insulin capsule, ORMD-0801, for the...

Via Benzinga

Short Volatility Alert: Oramed Pharmaceuticals Inc. ↗

July 21, 2022

On Wednesday, shares of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) experienced volatile short activity. After the activity, the stock price went up +4.16% to $8.77. The overall sentiment for ORMP has...

Via Benzinga

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session ↗

July 12, 2022

Gainers

Via Benzinga

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

Dow Rises 75 Points; Kura Sushi USA Shares Spike Higher ↗

July 08, 2022

U.S. stocks traded slightly higher toward the end of trading as investors digested the recent jobs report for the month of June.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 08, 2022

Via Benzinga

Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday ↗

June 24, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 03, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.